TP53 and prostate cancer: Here we quantified transcript levels of full-length p53 (FLTP53) and all TP53 isoforms using RT–qPCR in 122 prostate cancers from two separate cohorts of patients (n = 43; n = 79) and 3 non-neoplastic prostate samples.